VaxGen wins $80 million anthrax vaccine contract
Emergency Management Alert, October 8, 2003
Brisbane, CA-based biotechnology firm VaxGen won an $80.3 million federal contract on October 1 to continue development of a new genetically engineered anthrax vaccine, the Associated Press reports.
The three-year contract boosts VaxGen's chances of winning an even larger contract to manufacture the proposed $1.4 billion anthrax vaccine stockpile. The contract, awarded by the National Institute of Allergies and Infectious Diseases, funds animal and human experiments and lets the company manufacture three million doses of the vaccine.
VaxGen plans to test the vaccine's effectiveness on animals infected with anthrax; human volunteers will be injected with the experimental vaccine to determine its safety and whether it produces the desired immune response. The existing anthrax vaccine requires six shots over 18 months, plus an annual booster. VaxGen expects the new vaccine to require fewer shots.
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Answering service messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- Q&A: Coding for dry skin due to cold weather
- Are your workforce members texting PHI?
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- Catch up on what's new with injections and infusions
- Privacy, security concerns high in HIEs
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- HIPAA Q&A: Answering service messages
- Q&A: Coding for sepsis when other conditions are present
- Are your workforce members texting PHI?
- HIPAA Q&A: TPO disclosures to a business associate
- Q&A: Coding for dry skin due to cold weather
- What does case-mix index mean to you?
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- Searched
